Cabaletta Bio Balance Sheet Health
Financial Health criteria checks 6/6
Cabaletta Bio has a total shareholder equity of $199.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $217.4M and $17.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$203.23m |
| Equity | US$199.52m |
| Total liabilities | US$17.90m |
| Total assets | US$217.42m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CABA *'s short term assets ($206.3M) exceed its short term liabilities ($17.9M).
Long Term Liabilities: CABA * has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CABA * is debt free.
Reducing Debt: CABA * has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CABA * has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CABA * has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 31.7% each year.